title: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
authors.affiliation: Section of Endocrinology, Yale University School of Medicine and Yale-New Haven Hospital, New Haven, CT, USA.
authors.forename: S E
authors.initials: SE
authors.lastname: Inzucchi
authors.forename: R M
authors.initials: RM
authors.lastname: Bergenstal
authors.forename: J B
authors.initials: JB
authors.lastname: Buse
authors.forename: M
authors.initials: M
authors.lastname: Diamant
authors.forename: E
authors.initials: E
authors.lastname: Ferrannini
authors.forename: M
authors.initials: M
authors.lastname: Nauck
authors.forename: A L
authors.initials: AL
authors.lastname: Peters
authors.forename: A
authors.initials: A
authors.lastname: Tsapas
authors.forename: R
authors.initials: R
authors.lastname: Wender
authors.forename: D R
authors.initials: DR
authors.lastname: Matthews
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D019468:Disease Management; D005060:Europe; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy* / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D012955:Societies, Medical; D014481:United States
chemical_list: D007004:Hypoglycemic Agents